Free Trial

Talon Private Wealth LLC Purchases 8,382 Shares of Colgate-Palmolive Company $CL

Colgate-Palmolive logo with Consumer Staples background

Key Points

  • Talon Private Wealth LLC increased its holdings in Colgate-Palmolive by 213.7%, acquiring an additional 8,382 shares during the first quarter.
  • Colgate-Palmolive's quarterly earnings report showed an EPS of $0.92, beating estimates, with a revenue of $5.11 billion, up 1% year-over-year.
  • Analysts have set an average price target of $98.92 for Colgate-Palmolive, with ratings ranging from "Buy" to "Underweight."
  • MarketBeat previews top five stocks to own in October.

Talon Private Wealth LLC lifted its position in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 213.7% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 12,305 shares of the company's stock after buying an additional 8,382 shares during the quarter. Talon Private Wealth LLC's holdings in Colgate-Palmolive were worth $1,153,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in the company. Teza Capital Management LLC grew its holdings in Colgate-Palmolive by 80.3% during the 1st quarter. Teza Capital Management LLC now owns 15,607 shares of the company's stock worth $1,462,000 after acquiring an additional 6,950 shares in the last quarter. UniSuper Management Pty Ltd lifted its position in shares of Colgate-Palmolive by 16.3% in the 1st quarter. UniSuper Management Pty Ltd now owns 948,910 shares of the company's stock worth $88,913,000 after purchasing an additional 133,173 shares during the period. Richwood Investment Advisors LLC boosted its stake in shares of Colgate-Palmolive by 6.0% during the first quarter. Richwood Investment Advisors LLC now owns 4,132 shares of the company's stock valued at $387,000 after purchasing an additional 235 shares in the last quarter. Petrus Trust Company LTA bought a new position in shares of Colgate-Palmolive during the first quarter valued at approximately $315,000. Finally, Plancorp LLC increased its holdings in Colgate-Palmolive by 14.1% during the first quarter. Plancorp LLC now owns 10,856 shares of the company's stock valued at $1,017,000 after buying an additional 1,342 shares during the period. 80.41% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of analysts have weighed in on CL shares. Morgan Stanley lowered their target price on Colgate-Palmolive from $104.00 to $96.00 and set an "overweight" rating for the company in a report on Monday, August 4th. Barclays boosted their price target on Colgate-Palmolive from $86.00 to $87.00 and gave the stock an "equal weight" rating in a research report on Tuesday, July 15th. Citigroup decreased their price objective on Colgate-Palmolive from $108.00 to $105.00 and set a "buy" rating for the company in a research note on Monday, August 4th. Wells Fargo & Company dropped their price objective on Colgate-Palmolive from $88.00 to $83.00 and set an "underweight" rating on the stock in a research report on Monday, August 4th. Finally, UBS Group reduced their target price on shares of Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating for the company in a report on Thursday, July 17th. Seven equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $98.92.

Read Our Latest Stock Report on CL

Colgate-Palmolive Stock Up 1.7%

Colgate-Palmolive stock opened at $85.13 on Friday. Colgate-Palmolive Company has a 1-year low of $82.40 and a 1-year high of $109.04. The business has a fifty day moving average price of $86.74 and a 200-day moving average price of $89.76. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.57. The stock has a market capitalization of $68.80 billion, a price-to-earnings ratio of 23.91, a PEG ratio of 4.43 and a beta of 0.35.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its earnings results on Friday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.89 by $0.03. The company had revenue of $5.11 billion for the quarter, compared to analyst estimates of $5.03 billion. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The firm's quarterly revenue was up 1.0% compared to the same quarter last year. During the same period in the prior year, the company posted $0.91 EPS. Equities research analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 18th were given a $0.52 dividend. This represents a $2.08 annualized dividend and a dividend yield of 2.4%. The ex-dividend date of this dividend was Friday, July 18th. Colgate-Palmolive's dividend payout ratio (DPR) is presently 58.43%.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Recommended Stories

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Colgate-Palmolive Right Now?

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Massive Data Week Could Rock Markets — Here Are the Top Plays
Inside Retail: Where Smart Investors See the Upside
Not All AI Stocks Are Done — 4 With Huge Growth Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines